Premium
What will it take to refute the possible safety signal for dolutegravir and neural tube defects?
Author(s) -
Zash RM
Publication year - 2019
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.15864
Subject(s) - dolutegravir , pharmacovigilance , medicine , pregnancy , neural tube , obstetrics , pediatrics , neural tube defect , human immunodeficiency virus (hiv) , antiretroviral therapy , fetus , family medicine , viral load , adverse effect , genetics , embryo , biology , microbiology and biotechnology